Rohto Pharmaceutical Co.,Ltd.
4527
株式のランク
#3847
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
株価
$19.10
時価総額
$4.32B
変化(1日)
0.50%
変化(1年)
16.74%
国
JP
取引 Rohto Pharmaceutical Co.,Ltd. (4527)
カテゴリー
Consumer Defensive
Rohto Pharmaceutical Co.,Ltd.(4527)の発行済株式数
June 2026 時点の発行済株式数 225.96M
Rohto Pharmaceutical Co.,Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 225.96M です。March 2024 の終わりには、同社は 228.14M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Rohto Pharmaceutical Co.,Ltd.(4527)の発行済株式数の履歴(2008 ~ 2026)
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 225.96M | -0.81% |
| 2025 | 227.80M | -0.15% |
| 2024 | 228.14M | 0.00% |
| 2023 | 228.14M | 0.00% |
| 2022 | 228.14M | 0.00% |
| 2021 | 228.14M | 0.03% |
| 2020 | 228.08M | 0.07% |
| 2019 | 227.91M | 0.03% |
| 2018 | 227.83M | 0.07% |
| 2017 | 227.67M | 0.15% |
| 2016 | 227.34M | 0.16% |
| 2015 | 226.98M | -1.82% |
| 2014 | 231.19M | 0.00% |
| 2013 | 231.19M | 0.00% |
| 2012 | 231.19M | 0.00% |
| 2011 | 231.19M | 0.00% |
| 2010 | 231.19M | 0.00% |
| 2009 | 231.19M | 0.00% |
| 2008 | 231.19M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 2.42B | 972.07% |
US
|
|
| 533.97M | 136.31% |
FR
|
|
| 0.00 | -100.00% |
US
|
|
| 2.35B | 939.48% |
IN
|
|
| 362.30M | 60.34% |
US
|